Additionally, a recent experimental study of a breast cancer cell line revealed significantly greater expression of the DSC2 gene in HER2-positive patients and TNBC patients, and DSC2 overexpression was significantly correlated with shorter disease-free survival and overall survival. This evidence concerns the gene DSC2 and breast cancer.